- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
News
Article
Day 3 Recap: Elevate-Derm West 2024
Author(s):
Key Takeaways
- Tralokinumab effectively reduces genital atopic dermatitis severity and improves quality of life within three months.
- Affordable at-home treatments, such as microneedling and benzoyl peroxide, were highlighted for their cosmetic benefits.
Catch up on coverage from the third day of the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.
To stay informed with the latest conference insights, subscribe to receive our eNewsletters.
Real-World Data on Tralokinumab Demonstrates Effective Relief for Patients With Atopic Dermatitis Affecting the Genitals
The TRACE study showed tralokinumab reduced genital AD severity and improved quality of life within 3 months of treatment.
Updates on the Latest Cosmetic Treatments in Medical Care
Affordable at-home treatments, including microneedling and benzoyl peroxide, were top pearls at Chilukuri's Elevate-Derm session.
DELTA 2 Trial Shows Delgocitinib Cream Safe with Minimal Systemic Absorption for Chronic Hand Eczema
Delgocitinib cream offers a safe, low-systemic-exposure option for chronic hand eczema, according to a poster from the Elevate-Derm conference.
Latest Laser and Skincare Innovations for Hyperpigmentation with Suneel Chilukuri, MD, FAAD, FACMS
Chilukuri shared that 2 new sunscreen ingredients, physalis angulata and pycnogenol, can prevent heat-induced pigmentation, offering new options for patients.
CAB Gel Shows Promising Results for Hispanic Patients with Acne
The study demonstrated significant reductions in inflammatory and non-inflammatory lesions for Hispanic patients using CAB gel.
To view all conference coverage from Elevate-Derm West 2024, click here.
